I’m a holder of rgs but I tend to agree. No quantitative data in announcement and no news as to where next. More information is needed before a rerate. Though given our cash position and number of products in the pipeline I’m happy to keep this one in the bottom draw.
Ann: Regeneus Announces Successful Results in Acne Study, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.011M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7945 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 260 | 1 |
View Market Depth
| Last trade - 09.51am 23/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable